GLP-1 Buyer's Guide: What to Know Before You Start

I'm Dr. RightWell, Head of Department and physician-lead at RightWell, where we help everyday Americans access effective, sustainable weight management. If you've searched "GLP-1" recently, you're in good company. With over 820,000 monthly searches, this class of medications has changed how millions of people approach weight loss and metabolic health. Whether you're exploring GLP-1 pills, considering an injectable option, or just trying to understand what all the buzz is about, this guide gives you a clear, honest picture before you spend a dollar.

What Is GLP-1, Exactly?

GLP-1 (glucagon-like peptide-1) is a hormone your gut releases after you eat. It signals your pancreas to release insulin, tells your brain you're full, and slows stomach emptying. GLP-1 receptor agonist medications mimic this hormone, reducing hunger and supporting weight loss and blood sugar control.

GLP-1 stands for glucagon-like peptide-1. Your intestines release it naturally within minutes of a meal. It does three main jobs: it triggers insulin release from the pancreas, it slows how quickly food leaves your stomach, and it sends fullness signals to the hypothalamus in your brain.

GLP-1 receptor agonist medications copy this hormone's action, but they stay active far longer than the natural version. Natural GLP-1 breaks down in about 2 minutes. Pharmaceutical versions like semaglutide (the active ingredient in Ozempic and Wegovy) can last a full week per dose.

That extended action is why these drugs produce results that diet alone rarely achieves. Clinical trials published in the New England Journal of Medicine show semaglutide users losing an average of 15% of body weight over 68 weeks. Tirzepatide (Zepbound, Mounjaro) targets both GLP-1 and GIP receptors, and trials show up to 22% average weight loss.

The key word here is "average." Individual results depend on diet, activity, sleep quality, and whether you have the right support structure around you. That last factor is something RightWell was specifically built to address.

GLP-1 Medications Available in 2026: A Quick Comparison

The four most prescribed GLP-1 or dual-agonist medications in 2026 are: semaglutide injection (Ozempic/Wegovy), tirzepatide injection (Zepbound/Mounjaro), oral semaglutide (Rybelsus), and compounded semaglutide from licensed pharmacies.

Knowing your options makes the buying decision much clearer. Here is a fast breakdown of what is on the market right now.

Semaglutide injection (Ozempic / Wegovy): Weekly subcutaneous injection. Ozempic is FDA-approved for type 2 diabetes; Wegovy carries the weight-loss indication. Both use the same molecule at different doses. This is the medication most people mean when they say "glp-1 ozempic."

Tirzepatide injection (Zepbound / Mounjaro): Weekly injection targeting both GLP-1 and GIP receptors. Zepbound is the weight-loss brand; Mounjaro treats diabetes. Phase 3 trials show slightly stronger weight loss than semaglutide on average.

Oral semaglutide (Rybelsus): The only FDA-approved oral GLP-1 option. It requires specific timing (30 minutes before food, with a small amount of water) for adequate absorption. When people search "glp-1 pills," Rybelsus is the closest branded match.

Compounded semaglutide: Prepared by FDA-registered compounding pharmacies, typically at a lower GLP-1 cost than brand-name versions. Compounded formulas are not FDA-approved as finished drugs, so sourcing through a licensed medical provider matters enormously.

RightWell works with patients to identify which path fits their health history, insurance situation, and budget, then pairs that prescription with the nutritional and lifestyle support that actually makes results stick.

GLP-1 Side Effects: What to Expect (and What to Watch For)

The most common GLP-1 side effects are nausea, vomiting, diarrhea, and constipation. They are most intense during dose escalation and usually improve within 4 to 8 weeks. Rare but serious risks include pancreatitis and, in rodent studies, thyroid C-cell tumors.

No honest guide skips this part. GLP-1 side effects are real, and they are the number-one reason people quit before seeing meaningful results.

Common (affecting 10-40% of users):

• Nausea, especially during the first 4 weeks of a new dose
• Loose stool or constipation
• Burping or acid reflux
• Fatigue in the early weeks

Less common (affecting under 10%):

• Vomiting, usually tied to eating too fast or too large a meal
• Headaches during the first 1 to 2 weeks
• Injection-site reactions (redness, mild swelling)

Serious but rare:

• Acute pancreatitis. Discontinue and seek care immediately if you have severe upper-abdominal pain.
• Gallbladder disease. Rapid weight loss of any kind increases gallstone risk.
• Thyroid C-cell tumors were found in rodent studies at high doses. The FDA carries a boxed warning; the human clinical significance is still under study.

One practical tip: the nausea is almost always worse when patients try to eat normal-sized portions. Smaller meals, eaten slowly, cut the severity significantly. Staying well-hydrated helps too.

If you search "glp-1 reddit" for side effect stories, you will find a wide range, from people who felt almost nothing to people who stopped after 2 weeks. Context matters. Dose titration speed and whether a physician is actively monitoring you makes a large difference in how the experience goes. This is exactly why RightWell pairs medication access with ongoing medical oversight rather than just handing over a prescription.

How Much Does GLP-1 Therapy Actually Cost?

Brand-name GLP-1 medications cost $900 to $1,400 per month without insurance in 2026. With manufacturer savings cards, that can drop to under $25 per month for eligible patients. Compounded semaglutide typically costs $150 to $400 per month from licensed providers.

GLP-1 cost is the first question most people have after they decide the medications look promising. Here is an honest breakdown for 2026.

Brand-name without insurance: Wegovy lists at roughly $1,349 per month. Zepbound lists around $1,059 per month. These are retail list prices and most patients do not pay them.

With insurance: Coverage has expanded significantly since 2024. Many commercial plans now cover Wegovy or Zepbound with prior authorization for a BMI of 30 or higher (or 27 with a weight-related condition). Co-pays vary from $25 to $200 per month depending on the plan.

Savings cards: Novo Nordisk and Eli Lilly both offer savings programs. Commercially insured patients may pay as little as $25 per month through Wegovy's savings card, though these programs have income and insurance restrictions.

Compounded semaglutide: Prices through licensed telehealth and clinic programs typically run $150 to $400 per month. RightWell was founded specifically because the team recognized that most Americans couldn't sustain $1,200-a-month therapy on their own, and that affordability is part of making results sustainable.

Hidden costs to budget for: Lab work (roughly $50 to $150 depending on coverage), follow-up appointments, and any nutritional supplements your provider recommends. A good provider will be upfront about all of these.

The real cost question is not just monthly price. It's total value. Patients who have medical guidance, a support structure, and tools like a GLP-1 supplement to reinforce their progress tend to maintain results longer, which means the cost-per-pound-lost is actually lower over time.

GLP-1 Supplement vs. GLP-1 Medication: Understanding the Difference

A GLP-1 medication is a prescription drug that directly activates GLP-1 receptors. A GLP-1 supplement contains nutrients and botanicals (such as berberine, fiber, or bitter melon extract) that may support the body's natural GLP-1 signaling. Supplements do not replace prescriptions; they can complement them.

This distinction matters, and a lot of marketing in this space blurs it deliberately.

Prescription GLP-1 receptor agonists like semaglutide bind directly to GLP-1 receptors in the pancreas, gut, and brain with high affinity. The weight-loss effects documented in clinical trials come from this direct receptor activation.

A GLP-1 supplement works differently. Ingredients like berberine, inulin-type fructans, and certain plant extracts have evidence suggesting they support the body's own GLP-1 release or improve insulin sensitivity. They do not mimic the drug effect dose-for-dose. What they can do is reinforce a healthy metabolic environment, support gut health, and help you get more from your overall program.

Michael R., one of RightWell's patients, described it well: "I was already using a GLP-1 medication, but adding RightWell made a noticeable difference. My energy improved, my progress became more consistent, and I finally felt like I was on a sustainable path."Michael R.

RightWell's GLP-1 Boost is designed for exactly this role: to support GLP-1 signaling for people who are either on a prescription program and want to optimize their results, or who are not yet candidates for prescription therapy and want a science-backed first step. It is not a substitute for medical care. It is a tool within a broader plan.

If you are unsure which option fits your situation, the best starting point is a conversation with a physician who understands metabolic health, not a supplement label.

Who Is a Good Candidate for GLP-1 Therapy?

FDA guidelines support GLP-1 prescription therapy for adults with a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related condition such as type 2 diabetes, high blood pressure, or sleep apnea.

Clinical eligibility is fairly clear. The FDA approves GLP-1 medications for weight management in adults who meet one of these criteria:

• BMI of 30 or above
• BMI of 27 or above, plus at least one weight-related condition (type 2 diabetes, hypertension, dyslipidemia, obstructive sleep apnea, or cardiovascular disease)

That covers a significant portion of the U.S. adult population. But clinical eligibility is only one part of the picture.

Good candidates also tend to:

• Have tried dietary changes and exercise without achieving sustainable results
• Be prepared for a long-term commitment, not a 3-month fix
• Have or be willing to build support structures around their program
• Understand the side effect profile and have a physician monitoring their progress

Who should not use GLP-1 medications:

• Individuals with a personal or family history of medullary thyroid carcinoma
• People with a history of Multiple Endocrine Neoplasia syndrome type 2
• Those who are pregnant or planning to become pregnant in the near term
• Patients with a history of pancreatitis (discuss carefully with your physician)

RightWell's approach involves a full intake review before any medication recommendation. The goal, as the company was founded to achieve, is sustainable results, not short-term numbers. Sarah M. captured the long-view thinking that RightWell aims to instill: "After years of struggling with my weight, RightWell gave me the structure and support I needed. I've lost over 40 pounds and, for the first time, feel confident I can maintain my results long-term."

How RightWell Fits Into Your GLP-1 Journey

RightWell combines physician-led GLP-1 therapy, personalized nutritional support, and ongoing accountability into one program designed for everyday Americans who need more than a prescription to achieve lasting results.

Most people who try GLP-1 therapy without a support structure either plateau early, struggle with side effects they don't know how to manage, or regain weight when they stop the medication. That gap is exactly what RightWell was built to close.

The company was founded on a straightforward observation: prescriptions alone are not a complete solution. Successful long-term weight management requires medical guidance, nutritional strategy, and the kind of accountability that makes healthy habits stick. RightWell wraps all three around GLP-1 therapy.

Jennifer T. put it plainly: "RightWell helped me stay accountable and make healthier choices without feeling overwhelmed. The combination of medical guidance and ongoing support made the entire experience easier and more effective."

For patients who are actively on a GLP-1 prescription, RightWell's GLP-1 Boost supplement is designed to support GLP-1 signaling and complement the work the medication is already doing. For those who are not yet on a prescription, it can serve as a meaningful first step while they work through the medical evaluation process.

If you want to understand the full framework, including how medications, supplements, nutrition, and lifestyle habits work together in a coherent plan, the Complete GLP-1 Guide for 2026 walks through every layer in detail. That resource is the reference point this article builds from.

The bottom line is this: GLP-1 therapy is one of the most clinically validated tools available for weight loss right now. But tools only work when they are used correctly, consistently, and within a system designed to support you. That is what RightWell exists to provide.

Frequently asked questions

Related in this series

• GLP-1 Buyer's Guide: What to Know Before You Start (2026)